U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103278) titled 'A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers' on July 29.

Brief Summary: The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Benign Prostatic Hyperplasia

Intervention: DRUG: AD-116

AD-116 Oral Tablet

DRUG: AD-1161

AD-1161 Oral Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Disclaimer: Curated by HT Syndication....